| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Local | 45 | 2024 | 1005 | 10.440 |
Why?
|
| Tetrodotoxin | 28 | 2024 | 243 | 9.050 |
Why?
|
| Drug Delivery Systems | 58 | 2024 | 2238 | 8.910 |
Why?
|
| Nerve Block | 35 | 2024 | 716 | 7.200 |
Why?
|
| Anesthesia, Local | 21 | 2024 | 279 | 6.840 |
Why?
|
| Liposomes | 23 | 2024 | 793 | 6.260 |
Why?
|
| Bupivacaine | 28 | 2024 | 414 | 5.860 |
Why?
|
| Sciatic Nerve | 36 | 2024 | 628 | 5.380 |
Why?
|
| Delayed-Action Preparations | 27 | 2024 | 969 | 4.380 |
Why?
|
| Nanoparticles | 28 | 2024 | 1989 | 4.290 |
Why?
|
| Hydrogels | 21 | 2024 | 745 | 3.850 |
Why?
|
| Drug Carriers | 25 | 2024 | 710 | 3.760 |
Why?
|
| Biocompatible Materials | 35 | 2021 | 1703 | 3.620 |
Why?
|
| Hyaluronic Acid | 14 | 2015 | 488 | 3.170 |
Why?
|
| Polymers | 22 | 2024 | 1632 | 2.950 |
Why?
|
| Sodium Channel Blockers | 9 | 2023 | 173 | 2.720 |
Why?
|
| Nanomedicine | 10 | 2021 | 292 | 2.610 |
Why?
|
| Otitis Media | 5 | 2023 | 288 | 2.560 |
Why?
|
| Rats, Sprague-Dawley | 55 | 2023 | 8144 | 2.420 |
Why?
|
| Light | 13 | 2019 | 1355 | 2.220 |
Why?
|
| Gold | 10 | 2023 | 488 | 2.140 |
Why?
|
| Rats | 65 | 2024 | 23786 | 1.910 |
Why?
|
| Polyglycolic Acid | 13 | 2016 | 408 | 1.900 |
Why?
|
| Tympanic Membrane | 4 | 2023 | 232 | 1.750 |
Why?
|
| Contact Lenses | 7 | 2021 | 137 | 1.740 |
Why?
|
| Nanostructures | 7 | 2016 | 553 | 1.730 |
Why?
|
| Ciprofloxacin | 6 | 2018 | 313 | 1.680 |
Why?
|
| Infrared Rays | 6 | 2018 | 249 | 1.650 |
Why?
|
| Peritoneum | 7 | 2013 | 231 | 1.570 |
Why?
|
| Lactic Acid | 15 | 2016 | 1140 | 1.540 |
Why?
|
| Dexmedetomidine | 6 | 2018 | 320 | 1.480 |
Why?
|
| Animals | 141 | 2024 | 169335 | 1.460 |
Why?
|
| Ultrasonics | 4 | 2020 | 208 | 1.370 |
Why?
|
| Tissue Adhesions | 7 | 2013 | 223 | 1.370 |
Why?
|
| Cornea | 8 | 2022 | 1315 | 1.340 |
Why?
|
| Peritoneal Diseases | 5 | 2007 | 76 | 1.330 |
Why?
|
| Coated Materials, Biocompatible | 5 | 2016 | 311 | 1.300 |
Why?
|
| Nanotubes | 4 | 2018 | 83 | 1.260 |
Why?
|
| Prodrugs | 4 | 2024 | 275 | 1.250 |
Why?
|
| Materials Testing | 21 | 2017 | 873 | 1.230 |
Why?
|
| Hyperthermia, Induced | 3 | 2023 | 416 | 1.220 |
Why?
|
| Polyethylene Glycols | 8 | 2024 | 1197 | 1.220 |
Why?
|
| Anesthetics, Combined | 3 | 2018 | 43 | 1.210 |
Why?
|
| Metal Nanoparticles | 4 | 2014 | 406 | 1.200 |
Why?
|
| Cell Survival | 19 | 2020 | 5793 | 1.170 |
Why?
|
| Ultraviolet Rays | 8 | 2015 | 1104 | 1.150 |
Why?
|
| Microspheres | 14 | 2012 | 789 | 1.130 |
Why?
|
| Phototherapy | 4 | 2023 | 368 | 1.100 |
Why?
|
| Pharmaceutical Preparations | 5 | 2017 | 1088 | 1.080 |
Why?
|
| Tissue Adhesives | 3 | 2020 | 179 | 1.060 |
Why?
|
| Poloxamer | 3 | 2021 | 56 | 1.040 |
Why?
|
| Nanoshells | 2 | 2023 | 11 | 0.990 |
Why?
|
| Particle Size | 22 | 2017 | 1652 | 0.990 |
Why?
|
| Prostaglandins F, Synthetic | 2 | 2016 | 32 | 0.990 |
Why?
|
| Dexamethasone | 7 | 2021 | 1965 | 0.980 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2017 | 204 | 0.960 |
Why?
|
| Lipid Bilayers | 2 | 2023 | 379 | 0.940 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2024 | 395 | 0.930 |
Why?
|
| Nanocapsules | 2 | 2017 | 95 | 0.930 |
Why?
|
| Remote Sensing Technology | 3 | 2014 | 93 | 0.910 |
Why?
|
| Temperature | 7 | 2021 | 2235 | 0.900 |
Why?
|
| Technology, Pharmaceutical | 3 | 2014 | 84 | 0.880 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2018 | 506 | 0.880 |
Why?
|
| Photochemistry | 5 | 2013 | 238 | 0.860 |
Why?
|
| Polysorbates | 1 | 2023 | 46 | 0.860 |
Why?
|
| Polyesters | 5 | 2020 | 377 | 0.840 |
Why?
|
| Microscopy, Electron, Scanning | 15 | 2013 | 945 | 0.820 |
Why?
|
| Saxitoxin | 4 | 2015 | 65 | 0.820 |
Why?
|
| Lidocaine | 6 | 2013 | 546 | 0.810 |
Why?
|
| Adrenergic Agonists | 3 | 2017 | 57 | 0.800 |
Why?
|
| Anti-Bacterial Agents | 7 | 2023 | 7478 | 0.780 |
Why?
|
| Surface Properties | 8 | 2017 | 1169 | 0.780 |
Why?
|
| Keratitis | 2 | 2022 | 241 | 0.770 |
Why?
|
| Tissue Engineering | 9 | 2013 | 1893 | 0.770 |
Why?
|
| Polyethyleneimine | 2 | 2012 | 68 | 0.770 |
Why?
|
| Injections | 8 | 2024 | 841 | 0.770 |
Why?
|
| Rheology | 5 | 2021 | 348 | 0.760 |
Why?
|
| Capsaicin | 2 | 2019 | 235 | 0.760 |
Why?
|
| Drug Compounding | 6 | 2021 | 243 | 0.730 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2022 | 62 | 0.730 |
Why?
|
| Naloxone | 1 | 2023 | 372 | 0.730 |
Why?
|
| Magnetics | 4 | 2012 | 599 | 0.720 |
Why?
|
| Caseins | 1 | 2021 | 105 | 0.720 |
Why?
|
| Rhodamines | 1 | 2021 | 178 | 0.710 |
Why?
|
| Antifungal Agents | 3 | 2011 | 761 | 0.690 |
Why?
|
| Contact Lenses, Hydrophilic | 2 | 2011 | 53 | 0.680 |
Why?
|
| Microbubbles | 3 | 2024 | 137 | 0.680 |
Why?
|
| Tissue Scaffolds | 5 | 2014 | 951 | 0.660 |
Why?
|
| Excipients | 6 | 2021 | 98 | 0.650 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2016 | 414 | 0.650 |
Why?
|
| Photosensitizing Agents | 3 | 2019 | 630 | 0.650 |
Why?
|
| Permeability | 6 | 2019 | 726 | 0.630 |
Why?
|
| Chitosan | 7 | 2016 | 141 | 0.630 |
Why?
|
| Aptamers, Nucleotide | 2 | 2023 | 163 | 0.630 |
Why?
|
| Cross-Linking Reagents | 9 | 2012 | 692 | 0.620 |
Why?
|
| Membranes, Artificial | 2 | 2011 | 367 | 0.620 |
Why?
|
| Barium Compounds | 1 | 2018 | 19 | 0.620 |
Why?
|
| Fluorescein | 3 | 2024 | 175 | 0.610 |
Why?
|
| Mice | 46 | 2024 | 82072 | 0.600 |
Why?
|
| Nanocomposites | 3 | 2014 | 53 | 0.600 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2018 | 58 | 0.600 |
Why?
|
| Dextrans | 3 | 2009 | 574 | 0.600 |
Why?
|
| Rabbits | 13 | 2021 | 4774 | 0.580 |
Why?
|
| Polylysine | 3 | 2019 | 131 | 0.580 |
Why?
|
| Titanium | 2 | 2018 | 495 | 0.570 |
Why?
|
| Cell Death | 5 | 2013 | 1682 | 0.570 |
Why?
|
| Candida albicans | 2 | 2011 | 375 | 0.570 |
Why?
|
| Epinephrine | 4 | 2017 | 794 | 0.560 |
Why?
|
| Inorganic Chemicals | 1 | 2016 | 10 | 0.550 |
Why?
|
| Glaucoma | 3 | 2016 | 1194 | 0.550 |
Why?
|
| Barbiturates | 1 | 2017 | 113 | 0.540 |
Why?
|
| Palladium | 1 | 2017 | 67 | 0.540 |
Why?
|
| Polymethacrylic Acids | 2 | 2008 | 32 | 0.540 |
Why?
|
| Silicon Dioxide | 1 | 2017 | 218 | 0.540 |
Why?
|
| Tissue Distribution | 5 | 2019 | 2298 | 0.540 |
Why?
|
| Gels | 4 | 2011 | 423 | 0.540 |
Why?
|
| Chinchilla | 4 | 2018 | 77 | 0.540 |
Why?
|
| Acrylic Resins | 2 | 2014 | 135 | 0.530 |
Why?
|
| Carbamazepine | 1 | 2017 | 224 | 0.530 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2013 | 823 | 0.530 |
Why?
|
| Clonidine | 2 | 2015 | 170 | 0.510 |
Why?
|
| Nanotechnology | 5 | 2013 | 714 | 0.510 |
Why?
|
| Intraocular Pressure | 3 | 2016 | 1304 | 0.500 |
Why?
|
| Choroidal Neovascularization | 1 | 2019 | 364 | 0.490 |
Why?
|
| Radiation | 1 | 2015 | 48 | 0.490 |
Why?
|
| Nanowires | 2 | 2012 | 31 | 0.490 |
Why?
|
| Sonication | 2 | 2018 | 79 | 0.480 |
Why?
|
| Cell Line | 13 | 2019 | 15604 | 0.480 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8559 | 0.470 |
Why?
|
| Alkanesulfonic Acids | 1 | 2017 | 203 | 0.470 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2015 | 92 | 0.460 |
Why?
|
| Propoxycaine | 1 | 2013 | 6 | 0.440 |
Why?
|
| Skin, Artificial | 1 | 2014 | 89 | 0.440 |
Why?
|
| Biofouling | 1 | 2013 | 8 | 0.440 |
Why?
|
| Pneumococcal Infections | 1 | 2018 | 529 | 0.440 |
Why?
|
| Electric Conductivity | 2 | 2011 | 408 | 0.440 |
Why?
|
| Molecular Weight | 5 | 2016 | 2173 | 0.440 |
Why?
|
| Elasticity | 4 | 2017 | 657 | 0.440 |
Why?
|
| Methylcellulose | 2 | 2010 | 34 | 0.440 |
Why?
|
| Equipment Design | 8 | 2016 | 3530 | 0.430 |
Why?
|
| Coma | 1 | 2017 | 487 | 0.430 |
Why?
|
| Pain | 3 | 2019 | 5100 | 0.430 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 648 | 0.430 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 95 | 0.420 |
Why?
|
| Antidepressive Agents, Tricyclic | 2 | 2005 | 430 | 0.420 |
Why?
|
| Immunomagnetic Separation | 1 | 2013 | 79 | 0.420 |
Why?
|
| Streptococcus pneumoniae | 1 | 2018 | 764 | 0.420 |
Why?
|
| Graphite | 1 | 2013 | 79 | 0.420 |
Why?
|
| Diffusion | 5 | 2017 | 818 | 0.400 |
Why?
|
| Electronics, Medical | 1 | 2012 | 72 | 0.400 |
Why?
|
| Administration, Topical | 4 | 2021 | 704 | 0.400 |
Why?
|
| Mice, Nude | 6 | 2021 | 3631 | 0.390 |
Why?
|
| Econazole | 1 | 2011 | 4 | 0.390 |
Why?
|
| Blood Component Removal | 1 | 2013 | 132 | 0.390 |
Why?
|
| Male | 60 | 2021 | 365203 | 0.390 |
Why?
|
| Oxides | 1 | 2013 | 403 | 0.380 |
Why?
|
| Acrylates | 3 | 2008 | 75 | 0.380 |
Why?
|
| Adrenergic Antagonists | 2 | 2001 | 26 | 0.380 |
Why?
|
| Solvents | 1 | 2012 | 298 | 0.380 |
Why?
|
| Synaptic Vesicles | 1 | 2013 | 190 | 0.380 |
Why?
|
| Deoxycytidine | 1 | 2016 | 888 | 0.370 |
Why?
|
| Magnetite Nanoparticles | 1 | 2013 | 313 | 0.370 |
Why?
|
| Cyanoacrylates | 1 | 2011 | 47 | 0.370 |
Why?
|
| Injections, Subcutaneous | 6 | 2012 | 687 | 0.360 |
Why?
|
| Gadolinium | 1 | 2016 | 965 | 0.360 |
Why?
|
| Polymerization | 3 | 2018 | 155 | 0.360 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2016 | 790 | 0.360 |
Why?
|
| Doxorubicin | 3 | 2024 | 2234 | 0.360 |
Why?
|
| Humans | 83 | 2024 | 768970 | 0.350 |
Why?
|
| Molecular Structure | 6 | 2020 | 1885 | 0.350 |
Why?
|
| Viscosity | 4 | 2021 | 334 | 0.350 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2019 | 10765 | 0.350 |
Why?
|
| Chromatography, Affinity | 1 | 2011 | 525 | 0.350 |
Why?
|
| Microfluidics | 2 | 2013 | 674 | 0.350 |
Why?
|
| Blood | 1 | 2013 | 599 | 0.350 |
Why?
|
| Durapatite | 1 | 2011 | 167 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2019 | 3518 | 0.350 |
Why?
|
| Photochemical Processes | 3 | 2017 | 85 | 0.340 |
Why?
|
| Antibodies | 1 | 2018 | 2422 | 0.340 |
Why?
|
| Artificial Organs | 1 | 2011 | 149 | 0.340 |
Why?
|
| Sutures | 1 | 2012 | 283 | 0.340 |
Why?
|
| Keratinocytes | 1 | 2014 | 876 | 0.340 |
Why?
|
| Phospholipids | 2 | 2023 | 787 | 0.330 |
Why?
|
| Cytokines | 3 | 2018 | 7453 | 0.330 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 152 | 0.330 |
Why?
|
| Collagen | 2 | 2015 | 2646 | 0.320 |
Why?
|
| Cells, Cultured | 14 | 2015 | 19023 | 0.320 |
Why?
|
| Skin Transplantation | 1 | 2014 | 1097 | 0.320 |
Why?
|
| Sensory Receptor Cells | 2 | 2012 | 508 | 0.310 |
Why?
|
| Silicates | 1 | 2008 | 49 | 0.310 |
Why?
|
| Time Factors | 19 | 2019 | 40261 | 0.310 |
Why?
|
| Micelles | 2 | 2019 | 191 | 0.310 |
Why?
|
| Sphingomyelins | 1 | 2008 | 105 | 0.310 |
Why?
|
| Ferritins | 1 | 2011 | 600 | 0.310 |
Why?
|
| Skin | 4 | 2024 | 4506 | 0.310 |
Why?
|
| Ceftazidime | 1 | 2008 | 57 | 0.300 |
Why?
|
| Mycotoxins | 1 | 2008 | 35 | 0.300 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 1739 | 0.300 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 4 | 2004 | 40 | 0.300 |
Why?
|
| Acrylamides | 1 | 2009 | 261 | 0.290 |
Why?
|
| Fibroblasts | 4 | 2014 | 4179 | 0.290 |
Why?
|
| 3T3 Cells | 3 | 2021 | 1085 | 0.280 |
Why?
|
| Protons | 1 | 2013 | 1113 | 0.280 |
Why?
|
| Adhesiveness | 2 | 2021 | 52 | 0.280 |
Why?
|
| Neoplasms | 7 | 2020 | 22389 | 0.280 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2013 | 3782 | 0.280 |
Why?
|
| Cell Separation | 1 | 2013 | 1728 | 0.280 |
Why?
|
| Amphotericin B | 1 | 2007 | 143 | 0.280 |
Why?
|
| Ultrasonography | 3 | 2024 | 6002 | 0.280 |
Why?
|
| Candidiasis | 1 | 2009 | 367 | 0.280 |
Why?
|
| Wound Healing | 5 | 2020 | 2815 | 0.270 |
Why?
|
| Bandages, Hydrocolloid | 1 | 2006 | 8 | 0.270 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2021 | 1536 | 0.270 |
Why?
|
| Epithelium | 2 | 2008 | 1607 | 0.270 |
Why?
|
| Cellulose | 1 | 2006 | 117 | 0.270 |
Why?
|
| Cecal Diseases | 1 | 2006 | 49 | 0.270 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2013 | 1141 | 0.260 |
Why?
|
| Dextran Sulfate | 3 | 2016 | 258 | 0.260 |
Why?
|
| Chemistry, Pharmaceutical | 6 | 2016 | 275 | 0.260 |
Why?
|
| Bone Transplantation | 1 | 2011 | 925 | 0.260 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2012 | 1811 | 0.260 |
Why?
|
| Dopamine | 1 | 2013 | 1596 | 0.260 |
Why?
|
| Budesonide | 1 | 2007 | 162 | 0.260 |
Why?
|
| Drug Implants | 3 | 2014 | 230 | 0.260 |
Why?
|
| Injections, Intravenous | 3 | 2018 | 1379 | 0.260 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 18354 | 0.260 |
Why?
|
| Neuralgia | 1 | 2012 | 622 | 0.250 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 2059 | 0.250 |
Why?
|
| Myocytes, Cardiac | 3 | 2011 | 1682 | 0.250 |
Why?
|
| Flavoring Agents | 1 | 2005 | 53 | 0.240 |
Why?
|
| Cattle | 3 | 2018 | 3819 | 0.240 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 849 | 0.240 |
Why?
|
| Injections, Intraperitoneal | 3 | 2013 | 412 | 0.240 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 17173 | 0.240 |
Why?
|
| Staphylococcus aureus | 2 | 2013 | 1430 | 0.240 |
Why?
|
| NIH 3T3 Cells | 4 | 2017 | 669 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1658 | 0.240 |
Why?
|
| Implants, Experimental | 1 | 2005 | 99 | 0.240 |
Why?
|
| Surface Plasmon Resonance | 2 | 2017 | 272 | 0.240 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2004 | 56 | 0.240 |
Why?
|
| General Surgery | 2 | 2019 | 1722 | 0.230 |
Why?
|
| Prostheses and Implants | 1 | 2011 | 1279 | 0.230 |
Why?
|
| Peptides | 2 | 2014 | 4353 | 0.230 |
Why?
|
| Foreign-Body Reaction | 1 | 2005 | 156 | 0.230 |
Why?
|
| Chemokine CXCL12 | 3 | 2016 | 457 | 0.230 |
Why?
|
| Lactose | 2 | 2002 | 95 | 0.230 |
Why?
|
| Drug Synergism | 4 | 2018 | 1762 | 0.220 |
Why?
|
| Escherichia coli | 2 | 2013 | 4213 | 0.220 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 799 | 0.220 |
Why?
|
| Pain Threshold | 2 | 2018 | 606 | 0.220 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 13698 | 0.220 |
Why?
|
| Pyrroles | 1 | 2009 | 1125 | 0.210 |
Why?
|
| Forecasting | 1 | 2012 | 2945 | 0.210 |
Why?
|
| Kinetics | 3 | 2018 | 6332 | 0.210 |
Why?
|
| Muscimol | 1 | 2002 | 70 | 0.210 |
Why?
|
| Pheochromocytoma | 1 | 2005 | 328 | 0.210 |
Why?
|
| Solutions | 2 | 2016 | 410 | 0.200 |
Why?
|
| Sodium Channels | 2 | 2021 | 341 | 0.200 |
Why?
|
| Luminescence | 1 | 2022 | 108 | 0.200 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2019 | 1340 | 0.200 |
Why?
|
| Tetrazolium Salts | 2 | 2013 | 92 | 0.200 |
Why?
|
| Hot Temperature | 3 | 2005 | 1441 | 0.200 |
Why?
|
| Ultrasonic Therapy | 1 | 2024 | 217 | 0.200 |
Why?
|
| Models, Biological | 1 | 2018 | 9499 | 0.200 |
Why?
|
| Prenylation | 1 | 2021 | 37 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 1 | 2007 | 999 | 0.190 |
Why?
|
| Pharmacokinetics | 2 | 2012 | 86 | 0.190 |
Why?
|
| Photorefractive Keratectomy | 1 | 2021 | 34 | 0.190 |
Why?
|
| Anti-Infective Agents | 1 | 2009 | 984 | 0.190 |
Why?
|
| Alcohols | 1 | 2021 | 94 | 0.190 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 1165 | 0.190 |
Why?
|
| Pneumonia, Bacterial | 2 | 2018 | 320 | 0.190 |
Why?
|
| Carbon | 1 | 2005 | 672 | 0.190 |
Why?
|
| HeLa Cells | 4 | 2019 | 3076 | 0.180 |
Why?
|
| Histamine | 1 | 2023 | 496 | 0.180 |
Why?
|
| Serum Albumin | 2 | 2002 | 677 | 0.180 |
Why?
|
| Inflammation | 6 | 2023 | 10868 | 0.180 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2011 | 162 | 0.180 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 690 | 0.180 |
Why?
|
| Polyhydroxyethyl Methacrylate | 2 | 2011 | 30 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6401 | 0.170 |
Why?
|
| Chondroitin Sulfates | 2 | 2015 | 174 | 0.170 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 1276 | 0.170 |
Why?
|
| Electrochemistry | 2 | 2010 | 146 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 2488 | 0.170 |
Why?
|
| Boronic Acids | 1 | 2024 | 915 | 0.170 |
Why?
|
| Postoperative Complications | 7 | 2021 | 15889 | 0.170 |
Why?
|
| Pseudomonas Infections | 2 | 2018 | 623 | 0.170 |
Why?
|
| Drug Stability | 2 | 2013 | 292 | 0.170 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2005 | 735 | 0.170 |
Why?
|
| Mechanical Phenomena | 1 | 2021 | 143 | 0.170 |
Why?
|
| Transcytosis | 1 | 2019 | 48 | 0.170 |
Why?
|
| Nanoconjugates | 1 | 2019 | 22 | 0.170 |
Why?
|
| Azepines | 1 | 2021 | 329 | 0.170 |
Why?
|
| Fluoroquinolones | 1 | 2021 | 309 | 0.160 |
Why?
|
| Phosphatidylethanolamines | 1 | 2019 | 131 | 0.160 |
Why?
|
| Proteins | 2 | 2012 | 6011 | 0.160 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20245 | 0.160 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2019 | 44 | 0.160 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2013 | 553 | 0.160 |
Why?
|
| Catalysis | 2 | 2021 | 768 | 0.160 |
Why?
|
| Epilepsies, Partial | 1 | 2002 | 435 | 0.160 |
Why?
|
| Pseudomonas Vaccines | 1 | 2018 | 24 | 0.160 |
Why?
|
| Narcotic Antagonists | 1 | 2023 | 591 | 0.160 |
Why?
|
| Concanavalin A | 1 | 2018 | 190 | 0.160 |
Why?
|
| Xylazine | 1 | 2018 | 12 | 0.160 |
Why?
|
| Coumarins | 1 | 2019 | 119 | 0.160 |
Why?
|
| Amitriptyline | 2 | 2012 | 112 | 0.150 |
Why?
|
| Drug Administration Schedule | 2 | 2019 | 4862 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2014 | 3463 | 0.150 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2018 | 124 | 0.150 |
Why?
|
| Albumins | 3 | 2008 | 577 | 0.150 |
Why?
|
| Ovalbumin | 1 | 2020 | 677 | 0.150 |
Why?
|
| Peripheral Nerves | 1 | 2002 | 492 | 0.150 |
Why?
|
| Pentobarbital | 1 | 2018 | 153 | 0.150 |
Why?
|
| Hemodiafiltration | 1 | 2017 | 19 | 0.140 |
Why?
|
| Myoblasts | 2 | 2009 | 234 | 0.140 |
Why?
|
| Macrophages | 3 | 2007 | 5801 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 6512 | 0.140 |
Why?
|
| Self Administration | 1 | 2018 | 386 | 0.140 |
Why?
|
| Swine | 3 | 2018 | 5997 | 0.140 |
Why?
|
| Photochemotherapy | 3 | 2019 | 830 | 0.140 |
Why?
|
| Decontamination | 1 | 2017 | 73 | 0.140 |
Why?
|
| Heating | 1 | 2017 | 104 | 0.140 |
Why?
|
| Muscle, Skeletal | 3 | 2006 | 4978 | 0.140 |
Why?
|
| Cell Culture Techniques | 3 | 2011 | 1667 | 0.140 |
Why?
|
| Water | 2 | 2013 | 1421 | 0.140 |
Why?
|
| Uveitis | 1 | 2020 | 398 | 0.130 |
Why?
|
| Adhesives | 1 | 2017 | 67 | 0.130 |
Why?
|
| Haemophilus Infections | 1 | 2016 | 94 | 0.130 |
Why?
|
| Plasmapheresis | 1 | 2017 | 206 | 0.130 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2011 | 253 | 0.130 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 6320 | 0.130 |
Why?
|
| Ear, Middle | 1 | 2018 | 341 | 0.130 |
Why?
|
| Haemophilus influenzae | 1 | 2016 | 177 | 0.130 |
Why?
|
| Female | 22 | 2022 | 397515 | 0.130 |
Why?
|
| Carbohydrate Conformation | 1 | 2015 | 206 | 0.130 |
Why?
|
| Tonometry, Ocular | 1 | 2016 | 238 | 0.130 |
Why?
|
| Corneal Diseases | 1 | 2021 | 535 | 0.130 |
Why?
|
| Anterior Eye Segment | 1 | 2016 | 144 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2016 | 10486 | 0.120 |
Why?
|
| Cicatrix | 1 | 2021 | 799 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 1197 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 276 | 0.120 |
Why?
|
| Ruthenium Red | 1 | 2014 | 19 | 0.120 |
Why?
|
| Ophthalmic Solutions | 2 | 2021 | 312 | 0.120 |
Why?
|
| Carbocyanines | 1 | 2014 | 177 | 0.120 |
Why?
|
| Thiazoles | 2 | 2013 | 1542 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2014 | 848 | 0.110 |
Why?
|
| Macaca fascicularis | 1 | 2016 | 913 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 1371 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 11932 | 0.110 |
Why?
|
| Nitro Compounds | 1 | 2013 | 74 | 0.110 |
Why?
|
| Benzopyrans | 1 | 2013 | 63 | 0.110 |
Why?
|
| Catechols | 1 | 2013 | 63 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2016 | 504 | 0.110 |
Why?
|
| Behavior, Animal | 4 | 2004 | 1862 | 0.110 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 391 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2014 | 1305 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2018 | 1150 | 0.100 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2014 | 135 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 173 | 0.100 |
Why?
|
| Injections, Intramuscular | 2 | 2005 | 556 | 0.100 |
Why?
|
| Physicians | 1 | 2011 | 4607 | 0.100 |
Why?
|
| Biological Transport | 1 | 2017 | 2085 | 0.100 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2003 | 222 | 0.100 |
Why?
|
| Microtechnology | 1 | 2013 | 70 | 0.100 |
Why?
|
| Transistors, Electronic | 1 | 2012 | 23 | 0.100 |
Why?
|
| Hemofiltration | 1 | 2013 | 58 | 0.100 |
Why?
|
| Oils | 1 | 2012 | 54 | 0.100 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 320 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2002 | 1924 | 0.100 |
Why?
|
| Emulsions | 1 | 2012 | 152 | 0.100 |
Why?
|
| Toxicogenetics | 1 | 2012 | 19 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 1026 | 0.100 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 1064 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2016 | 2027 | 0.100 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2012 | 143 | 0.100 |
Why?
|
| Ketamine | 1 | 2018 | 527 | 0.100 |
Why?
|
| Motor Neurons | 2 | 2012 | 872 | 0.100 |
Why?
|
| Heparin | 2 | 2016 | 1636 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2019 | 65480 | 0.100 |
Why?
|
| Silk | 1 | 2012 | 93 | 0.100 |
Why?
|
| Motor Activity | 2 | 2017 | 2713 | 0.100 |
Why?
|
| Carbohydrates | 2 | 2005 | 389 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2018 | 791 | 0.100 |
Why?
|
| Nitrilotriacetic Acid | 1 | 2011 | 8 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 1967 | 0.100 |
Why?
|
| Administration, Inhalation | 3 | 2014 | 1169 | 0.100 |
Why?
|
| Calcium Channels, T-Type | 1 | 2011 | 28 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2167 | 0.100 |
Why?
|
| Electrophoresis | 1 | 2011 | 226 | 0.100 |
Why?
|
| Porosity | 2 | 2012 | 352 | 0.100 |
Why?
|
| Host vs Graft Reaction | 1 | 2011 | 13 | 0.100 |
Why?
|
| Hexuronic Acids | 1 | 2011 | 145 | 0.100 |
Why?
|
| Glucuronic Acid | 1 | 2011 | 150 | 0.100 |
Why?
|
| Optics and Photonics | 1 | 2013 | 307 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2014 | 563 | 0.100 |
Why?
|
| Elastic Modulus | 1 | 2012 | 211 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2015 | 1751 | 0.100 |
Why?
|
| Static Electricity | 1 | 2012 | 261 | 0.090 |
Why?
|
| Neutrophils | 1 | 2024 | 3785 | 0.090 |
Why?
|
| Desiccation | 1 | 2011 | 77 | 0.090 |
Why?
|
| Vaccines, Subunit | 2 | 2018 | 159 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2014 | 3102 | 0.090 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 694 | 0.090 |
Why?
|
| Pulmonary Edema | 1 | 2014 | 409 | 0.090 |
Why?
|
| Vaccines | 1 | 2020 | 843 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2016 | 1191 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 3 | 2014 | 2635 | 0.090 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 11521 | 0.090 |
Why?
|
| Photons | 1 | 2015 | 595 | 0.090 |
Why?
|
| Shear Strength | 1 | 2011 | 160 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1231 | 0.090 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 144 | 0.090 |
Why?
|
| Platelet-Rich Plasma | 1 | 2013 | 180 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2012 | 540 | 0.090 |
Why?
|
| Polymethyl Methacrylate | 1 | 2011 | 132 | 0.090 |
Why?
|
| Histidine | 1 | 2011 | 302 | 0.090 |
Why?
|
| Epithelium, Corneal | 1 | 2013 | 247 | 0.090 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2222 | 0.090 |
Why?
|
| Cell Size | 1 | 2012 | 626 | 0.090 |
Why?
|
| Corneal Ulcer | 1 | 2011 | 125 | 0.090 |
Why?
|
| Arsenites | 1 | 1990 | 65 | 0.090 |
Why?
|
| Nitrobenzenes | 1 | 2010 | 64 | 0.090 |
Why?
|
| Alginates | 1 | 2011 | 250 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 3 | 2021 | 6232 | 0.090 |
Why?
|
| Hippocampus | 1 | 2002 | 3782 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 36854 | 0.080 |
Why?
|
| Chelating Agents | 1 | 2011 | 385 | 0.080 |
Why?
|
| Formaldehyde | 1 | 2011 | 361 | 0.080 |
Why?
|
| Silicon | 2 | 2012 | 143 | 0.080 |
Why?
|
| Hypertension | 2 | 2005 | 8617 | 0.080 |
Why?
|
| Colloids | 1 | 2009 | 126 | 0.080 |
Why?
|
| Estrogens | 1 | 2016 | 1536 | 0.080 |
Why?
|
| Oligopeptides | 2 | 2012 | 1194 | 0.080 |
Why?
|
| Linear Models | 1 | 2019 | 5891 | 0.080 |
Why?
|
| Sodium Chloride | 2 | 2007 | 584 | 0.080 |
Why?
|
| Estradiol | 1 | 2016 | 1952 | 0.080 |
Why?
|
| Anesthesiology | 1 | 2019 | 1137 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3775 | 0.080 |
Why?
|
| Acute Disease | 1 | 2019 | 7245 | 0.080 |
Why?
|
| Survival | 1 | 2008 | 160 | 0.080 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 937 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2016 | 2395 | 0.080 |
Why?
|
| Capsules | 2 | 2005 | 193 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2012 | 1081 | 0.070 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.070 |
Why?
|
| Intracellular Space | 1 | 2009 | 199 | 0.070 |
Why?
|
| Career Choice | 1 | 2014 | 769 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1789 | 0.070 |
Why?
|
| Bronchitis | 1 | 2008 | 194 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2012 | 1493 | 0.070 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2008 | 139 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3838 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2010 | 564 | 0.070 |
Why?
|
| Absorbable Implants | 1 | 2009 | 338 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4356 | 0.070 |
Why?
|
| Metals | 1 | 2011 | 713 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2013 | 1024 | 0.070 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 1515 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2020 | 1252 | 0.070 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2006 | 199 | 0.070 |
Why?
|
| Muscle Cells | 1 | 2007 | 195 | 0.070 |
Why?
|
| Gum Arabic | 1 | 2005 | 3 | 0.070 |
Why?
|
| Food Preservation | 1 | 2005 | 13 | 0.060 |
Why?
|
| Base Sequence | 2 | 2014 | 12430 | 0.060 |
Why?
|
| Benzoates | 1 | 2007 | 213 | 0.060 |
Why?
|
| Ligands | 1 | 2013 | 3283 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 3952 | 0.060 |
Why?
|
| Sex Factors | 1 | 2019 | 10633 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2006 | 244 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 2149 | 0.060 |
Why?
|
| Enuresis | 1 | 2005 | 50 | 0.060 |
Why?
|
| Tyrosine | 1 | 2010 | 1427 | 0.060 |
Why?
|
| Indoles | 1 | 2013 | 1836 | 0.060 |
Why?
|
| Sterilization | 1 | 2006 | 132 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2006 | 1342 | 0.060 |
Why?
|
| Solubility | 1 | 2007 | 1087 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 3840 | 0.060 |
Why?
|
| Biomimetics | 1 | 2006 | 172 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2008 | 2089 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2003 | 1933 | 0.060 |
Why?
|
| HIV Infections | 1 | 2011 | 17591 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2005 | 354 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 1990 | 1165 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2007 | 744 | 0.060 |
Why?
|
| Freezing | 1 | 2005 | 311 | 0.060 |
Why?
|
| Plant Oils | 1 | 2005 | 199 | 0.060 |
Why?
|
| Morpholines | 1 | 2007 | 584 | 0.060 |
Why?
|
| Catecholamines | 1 | 2005 | 389 | 0.060 |
Why?
|
| Lactalbumin | 1 | 2003 | 20 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 13427 | 0.060 |
Why?
|
| Gelatin | 1 | 2005 | 231 | 0.060 |
Why?
|
| Pain Measurement | 3 | 2004 | 3586 | 0.060 |
Why?
|
| Eye Diseases | 1 | 2009 | 658 | 0.050 |
Why?
|
| Blood Chemical Analysis | 1 | 2005 | 436 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2006 | 755 | 0.050 |
Why?
|
| Vasodilation | 1 | 2007 | 967 | 0.050 |
Why?
|
| Protein Binding | 1 | 2015 | 9344 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1251 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2019 | 4756 | 0.050 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 2957 | 0.050 |
Why?
|
| Pilocarpine | 1 | 2002 | 64 | 0.050 |
Why?
|
| Uterine Contraction | 1 | 2003 | 91 | 0.050 |
Why?
|
| Lipids | 2 | 2005 | 3345 | 0.050 |
Why?
|
| Peripheral Nervous System | 1 | 2024 | 151 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 859 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 17629 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 22379 | 0.050 |
Why?
|
| Energy Transfer | 1 | 2022 | 109 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2015 | 739 | 0.050 |
Why?
|
| Myometrium | 1 | 2003 | 174 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 1990 | 1408 | 0.050 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2002 | 86 | 0.050 |
Why?
|
| Connective Tissue | 1 | 2005 | 425 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 1601 | 0.050 |
Why?
|
| Aorta | 1 | 1990 | 2046 | 0.050 |
Why?
|
| Injections, Intraventricular | 1 | 2002 | 227 | 0.050 |
Why?
|
| Sample Size | 1 | 2005 | 848 | 0.050 |
Why?
|
| Complement Activation | 1 | 2024 | 447 | 0.050 |
Why?
|
| Vocal Cords | 1 | 2006 | 520 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2009 | 2126 | 0.050 |
Why?
|
| Acetone | 1 | 2021 | 44 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2012 | 5404 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2012 | 1672 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2001 | 154 | 0.050 |
Why?
|
| Phentolamine | 1 | 2001 | 102 | 0.050 |
Why?
|
| Pertussis Toxin | 1 | 2001 | 176 | 0.050 |
Why?
|
| Neurofibromatoses | 1 | 2005 | 303 | 0.050 |
Why?
|
| Aqueous Humor | 1 | 2021 | 152 | 0.050 |
Why?
|
| Lasers, Excimer | 1 | 2021 | 68 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2001 | 398 | 0.050 |
Why?
|
| Muscles | 1 | 2005 | 1582 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2021 | 277 | 0.040 |
Why?
|
| Mesothelioma | 1 | 2007 | 811 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2006 | 1153 | 0.040 |
Why?
|
| Models, Animal | 1 | 2007 | 2122 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2021 | 405 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2001 | 293 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3928 | 0.040 |
Why?
|
| Amides | 2 | 2003 | 452 | 0.040 |
Why?
|
| Lethal Dose 50 | 1 | 2000 | 71 | 0.040 |
Why?
|
| Abdomen | 1 | 2006 | 1137 | 0.040 |
Why?
|
| Glycosides | 1 | 2020 | 100 | 0.040 |
Why?
|
| Tears | 1 | 2021 | 253 | 0.040 |
Why?
|
| Aging | 1 | 1998 | 8745 | 0.040 |
Why?
|
| Posterior Eye Segment | 1 | 2019 | 18 | 0.040 |
Why?
|
| Brain | 2 | 2005 | 27453 | 0.040 |
Why?
|
| Fluorescence | 1 | 2021 | 757 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1999 | 157 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2862 | 0.040 |
Why?
|
| Aerosols | 2 | 2013 | 636 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 154 | 0.040 |
Why?
|
| Neurons, Afferent | 1 | 2000 | 498 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2004 | 1895 | 0.040 |
Why?
|
| Headache | 1 | 2005 | 1264 | 0.030 |
Why?
|
| Apnea | 1 | 1998 | 195 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2007 | 2029 | 0.030 |
Why?
|
| Cytosol | 1 | 2020 | 886 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 485 | 0.030 |
Why?
|
| Muramidase | 1 | 2016 | 163 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2017 | 335 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2018 | 622 | 0.030 |
Why?
|
| Pyridines | 1 | 2007 | 2895 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 2725 | 0.030 |
Why?
|
| Steroids | 1 | 2020 | 938 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2007 | 3048 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3702 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39394 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 344 | 0.030 |
Why?
|
| Nociceptors | 1 | 1998 | 460 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 1998 | 657 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2016 | 594 | 0.030 |
Why?
|
| Drug Design | 1 | 2019 | 1046 | 0.030 |
Why?
|
| Monocrotaline | 1 | 2013 | 26 | 0.030 |
Why?
|
| Radiography | 1 | 2005 | 6991 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2009 | 12806 | 0.030 |
Why?
|
| Fluorescein Angiography | 1 | 2019 | 1086 | 0.030 |
Why?
|
| Child | 2 | 2016 | 80960 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 5505 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11684 | 0.030 |
Why?
|
| Neurons | 2 | 2002 | 9519 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2018 | 5906 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 244 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2018 | 925 | 0.030 |
Why?
|
| Lung | 3 | 2018 | 10099 | 0.020 |
Why?
|
| Vaccination | 1 | 2004 | 3438 | 0.020 |
Why?
|
| Ventilators, Mechanical | 1 | 2014 | 292 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2015 | 600 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2014 | 415 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2019 | 1356 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 665 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3813 | 0.020 |
Why?
|
| Desoxycorticosterone | 1 | 1990 | 46 | 0.020 |
Why?
|
| Oxygen | 1 | 2001 | 4272 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 13021 | 0.020 |
Why?
|
| Glucose | 1 | 2001 | 4352 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 7058 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2014 | 738 | 0.020 |
Why?
|
| Absorption | 1 | 2009 | 244 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 21188 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2087 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 89244 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4939 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1990 | 1553 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2001 | 3008 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3538 | 0.020 |
Why?
|
| Retina | 1 | 2019 | 2661 | 0.020 |
Why?
|
| Purinones | 1 | 2007 | 13 | 0.020 |
Why?
|
| Methionine | 1 | 1990 | 573 | 0.020 |
Why?
|
| Powders | 1 | 2007 | 79 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2007 | 94 | 0.020 |
Why?
|
| Serum | 1 | 2009 | 207 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1990 | 899 | 0.020 |
Why?
|
| Respiration | 1 | 2014 | 1668 | 0.020 |
Why?
|
| Angiotensin II | 1 | 1990 | 844 | 0.020 |
Why?
|
| Arsenic | 1 | 1990 | 358 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2007 | 206 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2007 | 213 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 394 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 797 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2006 | 238 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2827 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2474 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10115 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 170 | 0.020 |
Why?
|
| Apoptosis | 1 | 2001 | 9527 | 0.020 |
Why?
|
| Quinoxalines | 1 | 2007 | 297 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6526 | 0.020 |
Why?
|
| Hydrazines | 1 | 2006 | 223 | 0.020 |
Why?
|
| Myoblasts, Skeletal | 1 | 2005 | 74 | 0.020 |
Why?
|
| Sheep | 1 | 2007 | 1451 | 0.010 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2004 | 98 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5216 | 0.010 |
Why?
|
| Spheroids, Cellular | 1 | 2006 | 331 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2019 | 5110 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2004 | 241 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4339 | 0.010 |
Why?
|
| Procaine | 1 | 2003 | 60 | 0.010 |
Why?
|
| Photography | 1 | 2006 | 537 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 2094 | 0.010 |
Why?
|
| Cell Polarity | 1 | 2006 | 639 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1973 | 0.010 |
Why?
|
| Medication Adherence | 1 | 2014 | 2192 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2001 | 88 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2009 | 1735 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6086 | 0.010 |
Why?
|
| Calcium | 1 | 2014 | 5792 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9442 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2004 | 460 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 1356 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2683 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2004 | 9565 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 2004 | 996 | 0.010 |
Why?
|
| RNA | 1 | 1990 | 2727 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 4056 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2005 | 1110 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2003 | 1890 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1676 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 1245 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2019 | 26428 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2004 | 1530 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 6131 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2007 | 2149 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 1363 | 0.010 |
Why?
|
| Regeneration | 1 | 2006 | 1524 | 0.010 |
Why?
|
| Monocytes | 1 | 2004 | 2603 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2004 | 2748 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 4428 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2005 | 3592 | 0.010 |
Why?
|
| United States | 1 | 2019 | 73186 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2004 | 4651 | 0.010 |
Why?
|
| Phenotype | 1 | 2001 | 16731 | 0.000 |
Why?
|
| Pregnancy | 1 | 2003 | 30265 | 0.000 |
Why?
|